Orthofix Medical Inc (OFIX) Stock Forecast & Price Target
Orthofix Medical Inc · NASDAQ
$11.89+0.64 (+5.69%)
15-min delayed · Jul 27, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 4 firms covering Orthofix Medical Inc, 3 rate it Buy or better, 1 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $14.00 to $18.00, so the covering firms are broadly aligned. The average target of $16.00 sits 35% above the current $11.89. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $0.08 next quarter toward $0.84 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS4 ratings
Moderate Buy
Strong Buy00%
Buy375%
Hold125%
Sell00%
Strong Sell00%
Based on 4 analysts giving stock ratings to Orthofix Medical Inc.
As of Jul, 3 of 4 firms rate OFIX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
OFIX EPS & revenue forecast
EPS · NEXT QUARTER
$0.08
Range $0.08 – $0.08 · 1 analysts · -60% YoY
Next period, 1 analysts expect Orthofix Medical Inc to earn $0.08 a share (range $0.08 – $0.08), versus $0.20 a year earlier. Full-year consensus is $0.27, growing to $0.84 the year after.
REVENUE · NEXT QUARTER
$211.2M
Range $209.5M – $214.0M · 1 analysts · +3% YoY
Revenue is expected to reach $211.2M (range $209.5M – $214.0M), +2.7% year-over-year. Full-year consensus is $843.3M, rising to $885.7M next year.
Top analysts covering Orthofix Medical Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on OFIX.
#1
David Turkaly
JMP Securities · Rank #276
Hold
No targeton OFIX
Overall win rate
31%
+ Follow
#2
Michael Petusky
Barrington Research · Rank #322
Buy
$17.00+43.0% to target
Overall win rate
29%
+ Follow
#3
CB
Caitlin Burrows
Canaccord Genuity
Buy
$18.00+51.4% to target
Coverage
—
+ Follow
#4
TS
Thomas Stephan
Stifel
Buy
$15.00+26.2% to target
Coverage
—
+ Follow
#5
JW
Jason Wittes
Roth MKM
Buy
$22.00+85.0% to target
Coverage
—
+ Follow
OFIX stock forecast FAQ
What is OFIX's average 12-month price target?+
The 4 analysts with a live target average $16.00 for Orthofix Medical Inc over the next 12 months, ranging from a $18.00 high to a $14.00 low.
Is OFIX stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 4 analyst ratings, 3 are Buy or Strong Buy, 1 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for OFIX?+
The Street-high target is $18.00 (Canaccord Genuity), and the Street-low is $14.00 (TD Cowen). The average of all 4 active targets is $16.00.
How many Wall Street analysts cover OFIX?+
4 analysts have an active rating on Orthofix Medical Inc, and 4 firms carry a live 12-month price target.
Who is the most accurate analyst covering OFIX?+
Among analysts who currently cover OFIX, David Turkaly of JMP Securities has the strongest overall Quantellect track record (Rank #276). Their current call is Hold.
What is Orthofix Medical Inc's projected EPS for next quarter?+
The consensus estimate is $0.08 per share (range $0.08 – $0.08) across 1 analysts. Full-year EPS is projected at $0.27, rising to $0.84 the following year.
How much revenue is Orthofix Medical Inc expected to report next quarter?+
Consensus revenue is $211.2M (range $209.5M – $214.0M). Full-year revenue is projected at $843.3M, growing to $885.7M next year.
Have analysts been upgrading or downgrading OFIX lately?+
As of Jul, 3 of 4 firms rate OFIX a Buy (1 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their OFIX calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
